Spinal Cord Stimulation to Restore Cough
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this trial is to determine the efficacy of spinal cord stimulation to produce an effective cough in patients with spinal cord injuries.
| Condition | Intervention |
|---|---|
|
Spinal Cord Injuries Spinal Cord Diseases Paralysis Central Nervous System Diseases Cough Trauma, Nervous System Wounds and Injuries |
Procedure: Spinal Cord Stimulation Device: Expiratory Muscle Stimulator |
| Study Type: | Interventional |
| Study Design: | Endpoint Classification: Safety/Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Spinal Cord Stimulation to Restore Cough |
- Measurements of airway pressure, expired volume and expiratory flow rate to evaluate efficacy of cough. [ Time Frame: one year ] [ Designated as safety issue: No ]
- Assessment of need for caregiver support for secretion removal. [ Time Frame: one year ] [ Designated as safety issue: No ]
- Assessment of ease in expectoration of secretions. [ Time Frame: one year ] [ Designated as safety issue: No ]
- Incidence of respiratory tract infections. [ Time Frame: one year ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 18 |
| Study Start Date: | September 2004 |
| Estimated Study Completion Date: | March 2013 |
| Estimated Primary Completion Date: | September 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: 1
Procedure/Surgery: spinal cord stimulation
|
Procedure: Spinal Cord Stimulation
Participants will have small electrodes (metal discs) placed — by a routine surgical procedure — over the surface of their spinal cords on the lower back to stimulate the expiratory muscles and restore cough. These electrodes are then activated at subsequent study visits using the external control unit.
Device: Expiratory Muscle Stimulator
The expiratory muscle stimulator consists of three small electrodes (metal discs) implanted over the surface of their spinal cords on the lower back to stimulate the expiratory muscles and restore cough. These electrodes are connected to an implanted receiver in the abdomen or chest wall. The device is activated through an external antenna connected to an external control box.
|
Detailed Description:
Patients with cervical and thoracic spinal cord injuries often have paralysis of a major portion of their expiratory muscles — the muscles responsible for coughing — and therefore, lack a normal cough mechanism. Consequently, most of these patients suffer from a markedly reduced ability to clear airway secretions, a factor which contributes to the development of recurrent respiratory tract infections such as pneumonia and bronchitis. Expiratory muscles can be activated by electrical stimulation of the spinal roots to produce a functionally effective cough.
The purpose of this trial is to determine if electrical stimulation of the expiratory muscles is capable of producing an effective cough on demand. According to the trial researchers, if successful, this technique will prevent the need for frequent patient suctioning — which often requires the constant presence of trained personnel. It will also allow spinal cord injured patients to clear their secretions more readily, thereby reducing the incidence of respiratory complications and associated illness and death.
In the trial, researchers will study 18 adults (18-70 years old) with spinal injuries (T5 level or higher), at least 12 months following the date of injury. After an evaluation of medical history, a brief physical examination, and initial testing, participants will have small electrodes (metal discs) placed — by a routine surgical procedure — over the surface of their spinal cords on the lower back to stimulate the expiratory muscles and restore cough.
Eligibility| Ages Eligible for Study: | 18 Years to 70 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Stable spinal cord injury T5 level or higher
- Expiratory muscle weakness
Exclusion Criteria:
- Significant cardiovascular disease
- Active lung disease
- Brain disease
- Scoliosis, chest wall deformity, or marked obesity
Contacts and Locations| United States, Ohio | |
| MetroHealth Medical Center | |
| Cleveland, Ohio, United States, 44109 | |
| Principal Investigator: | Anthony F. DiMarco, MD | MetroHealth Medical Center |
More Information
Publications:
| Responsible Party: | Anthony F. DiMarco, Professor of Medicine, Case Western Reserve University |
| ClinicalTrials.gov Identifier: | NCT00116337 History of Changes |
| Other Study ID Numbers: | R01NS049516/RC1NS068576, IRB 98-00091, RC1NS068576 |
| Study First Received: | June 28, 2005 |
| Last Updated: | May 23, 2012 |
| Health Authority: | United States: Food and Drug Administration |
Keywords provided by Case Western Reserve University:
|
spinal cord injury paralysis cough cervical spinal cord injury thoracic spinal cord injury |
Additional relevant MeSH terms:
|
Central Nervous System Diseases Cough Nervous System Diseases Retinitis Pigmentosa Spinal Cord Diseases Spinal Cord Injuries Wounds and Injuries Paralysis Trauma, Nervous System Respiration Disorders |
Respiratory Tract Diseases Signs and Symptoms, Respiratory Signs and Symptoms Eye Diseases, Hereditary Eye Diseases Retinal Dystrophies Retinal Degeneration Retinal Diseases Genetic Diseases, Inborn Neurologic Manifestations |
ClinicalTrials.gov processed this record on June 18, 2013